In this session Dr Nina Fuller-Shavel will explore indications and practical considerations for Helixor mistletoe therapy use within the overall integrative oncology plan and provide an outline of the subcutaneous and intravenous mistletoe service available at her award-winning multidisciplinary practice, Synthesis Clinic, including safety data. Alongside direct patient feedback on personal impact of mistletoe therapy, Dr Fuller-Shavel will examine brief case studies from her practice that illustrate the effects that Helixor mistletoe can have on biomarkers, medical treatment outcomes and quality of life, as well as discussing how the intersection between precision oncology and integrative oncology can guide clinical practice.